SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-22-159742
Filing Date
2022-05-25
Accepted
2022-05-25 16:31:44
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 d349919ds3.htm S-3 199235
2 EX-5.1 d349919dex51.htm EX-5.1 7866
3 EX-23.1 d349919dex231.htm EX-23.1 1624
4 EX-FILING FEES d349919dexfilingfees.htm EX-FILING FEES 40794
5 GRAPHIC g349919g03p10.jpg GRAPHIC 46636
6 GRAPHIC g349919g33x80.jpg GRAPHIC 8455
  Complete submission text file 0001193125-22-159742.txt   322377
Mailing Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404
Business Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Filer) CIK: 0001759425 (see all company filings)

IRS No.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-265210 | Film No.: 22963358
SIC: 2834 Pharmaceutical Preparations